223 related articles for article (PubMed ID: 19408055)
1. Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia.
Gumbs AA; Zain J; Neylon E; MacGregor-Cortelli B; Patterson M; O'Connor OA
Ann Surg Oncol; 2009 Jul; 16(7):2014-7. PubMed ID: 19408055
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoma without lymphadenopathy.
Kini U; Alexander B; Correa M
J Assoc Physicians India; 2008 May; 56():383-5. PubMed ID: 18700647
[TBL] [Abstract][Full Text] [Related]
3. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
4. [Primary hepatosplenic (gamma delta) T-cell lymphoma: clinico-pathologic analysis of 3 cases].
Plank L; Fricová M; Stecová N; Tóthová E; Mudronová B; Fuschsberger P; Mociková K; Genserková H; Kreze O; Mociková H
Vnitr Lek; 1998 Sep; 44(9):528-34. PubMed ID: 10358463
[TBL] [Abstract][Full Text] [Related]
5. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
[No Abstract] [Full Text] [Related]
6. Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms.
Shi Y; Wang E
Arch Pathol Lab Med; 2015 Sep; 139(9):1173-80. PubMed ID: 26317456
[TBL] [Abstract][Full Text] [Related]
7. Pralatrexate: an emerging new agent with activity in T-cell lymphomas.
O'Connor OA
Curr Opin Oncol; 2006 Nov; 18(6):591-7. PubMed ID: 16988580
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow.
Ahmad E; Kingma DW; Jaffe ES; Schrager JA; Janik J; Wilson W; Stetler-Stevenson M
Cytometry B Clin Cytom; 2005 Sep; 67(1):6-12. PubMed ID: 15973700
[TBL] [Abstract][Full Text] [Related]
9. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
[TBL] [Abstract][Full Text] [Related]
10. Hepatosplenic gamma-delta T-cell lymphoma.
Ferreri AJ; Govi S; Pileri SA
Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
[TBL] [Abstract][Full Text] [Related]
11. Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
Corazzelli G; Capobianco G; Russo F; Frigeri F; Aldinucci D; Pinto A
Haematologica; 2005 Mar; 90(3):ECR14. PubMed ID: 15753055
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
13. Primary splenic lymphoma.
Isaacson PG
Cancer Surv; 1997; 30():193-212. PubMed ID: 9547993
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma.
Foss FM
Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1141-52. PubMed ID: 21726160
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic gamma delta T-cell lymphoma with a novel cytogenetic alteration and cerebrospinal fluid infiltration: biological and clinical features.
Ferrari D; Girmenia G; Migliorini L; Nosari A; Morra E
Haematologica; 2002 Mar; 87(3):ECR11. PubMed ID: 11869957
[No Abstract] [Full Text] [Related]
16. Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma.
Shetty S; Mansoor A; Roland B
Cancer Genet Cytogenet; 2006 Jun; 167(2):161-3. PubMed ID: 16737917
[TBL] [Abstract][Full Text] [Related]
17. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
Geng J; Zhu MG; Ding YQ; Han HX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
[TBL] [Abstract][Full Text] [Related]
18. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
[TBL] [Abstract][Full Text] [Related]
19. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
[TBL] [Abstract][Full Text] [Related]
20. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
